PFS
BBH icon

Prospera Financial Services’s VanEck Biotech ETF BBH Stock Holding History

Prospera Financial Services’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-250
Closed -$41K – 750
2020
Q3 		$41K Buy
+250
New +$40.7K 0.02% 682

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Prospera Financial Services's BBH Position: Q4 2020 in Review

Prospera Financial Services sold out of VanEck Biotech ETF (BBH) in Q4 2020, closing a stake of 250 shares — an estimated $41K sold.

Prospera Financial Services first reported a position in BBH in Q3 2020 and held it in 1 quarter. The position peaked at $41K in Q3 2020. 108 funds tracked by Wall St. Rank hold BBH as of Q4 2020.

  • Prospera Financial Services reported no remaining VanEck Biotech ETF position as of Q4 2020 after selling out during the quarter.
  • Prospera Financial Services sold 250 VanEck Biotech ETF shares in Q4 2020, an estimated $41K.
  • Prospera Financial Services first reported a position in VanEck Biotech ETF in Q3 2020 and held it in 1 quarter.
  • Prospera Financial Services's VanEck Biotech ETF position peaked at $41K in Q3 2020.
  • 108 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2020.

Based on Prospera Financial Services's 13F filing for Q4 2020, filed 12 Feb 2021.